USPTO serial 76272272
PROTEOCHIP
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- PIGNATELLO, ELIZABETH
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with PROTEOCHIP?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
72076 Tubingen, DE
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Gary M. Nath
GARY M NATH NATH & ASSOCIATES PLLC1030 FIFTEENTH ST N WSIXTH FLWASHINGTON, DC 20005Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemicals for use in scientific research, namely for the affinity binding, quantification and/or identification of proteins, groups of proteins, or post-translational modifications of proteins or groups thereof, and chemicals for use in industry, namely for the affinity binding, quantification and/or identification of proteins, groups of proteins, or post-translational modifications of proteins or groups thereof; reagents containing proteins and peptides for scientific or research use | ACTIVE | — |
| 005 | Pharmaceutical preparations for the treatment of AIDS, myelopathy, Parkinson's disease, Alzheimer's Disease, cardiovascular diseases, stroke, epilepsy, multiple sclerosis, cancer and diabetes; veterinary preparations for use in the treatment of pets or livestock; dietetic substances adapted for medical use, namely, dietary supplements; preparations for destroying vermin; fungicides and herbicides for domestic and agricultural use | ACTIVE | — |
| 009 | Scientific computer programs for use in database management and bioinformatics; scientific apparatus, namely apparatus for the affinity binding and quantification of proteins, groups of proteins, groups of proteins, or post-translational modifications of proteins or groups thereof, and instruments, namely instruments for the affinity binding and quantification of proteins, groups of proteins, or post-translational modifications of proteins or groups thereof, for use in genomics research, proteomics research, medical research, biotechnological research and food research; diagnostic apparatus, namely apparatus for the affinity binding and quantification of proteins, groups of proteins, or post-translational modifications of proteins or groups thereof, and instruments, namely instruments for the affinity binding and quantification of proteins, groups of proteins, or post-translational modifications of proteins or groups thereof, for use in genomics research, and instruments for analysis of chemical and biological substances, in particular for the analysis of proteins and protein mixtures; optically based, electronically based, radioactively based, magnetically based, mechanically based, physically based, or biologically based detection systems coupled with analog or digital data measuring and data carriers that are used with applied chemical and biochemical substances, in particular with applied peptides and proteins; and parts for all the aforementioned goods | ACTIVE | — |
| 042 | Medical and veterinary services; agricultural research services; medical and scientific diagnostic testing, namely, in diagnosing AIDS, myelopathy, Parkinson's Disease, Alzheimer's Disease, cardiovascular diseases, stroke, epilepsy, multiple sclerosis, cancer and diabetes; scientific, medical and industrial research and product development; laboratory research in the field of protein analysis and protein mixtures | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by ProteoMed GmbH
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 042
- Similar marks named PROTEOCHIP
- Prosecution event ABN2 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 22, 2004 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Dec 8, 2003 | CNSI | INQUIRY AS TO SUSPENSION MAILED | — |
| Dec 3, 2003 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 15, 2003 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 15, 2003 | CFIT | CASE FILE IN TICRS | — |
| Nov 14, 2002 | CNSL | LETTER OF SUSPENSION MAILED | — |
| Jul 9, 2002 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 9, 2002 | PAPER RECEIVED | — | |
| Jul 1, 2002 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 1, 2002 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 19, 2002 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 19, 2001 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 21, 2001 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 15, 2001 | DOCK | ASSIGNED TO EXAMINER | — |